Well, the cat is out of the bag. The product Teva is trying to pass off to the FDA as a generic copy of Lovenox was developed by ItalFarmaco and is manufactured by ItalFarmaco. It’s the same product Lupin sells in India under the brand name, Lupenox (#msg-56014815). Teva’s contribution is limited to FDA regulatory submissions and prospective US distribution. As presented in #msg-55885444 and #msg-55952595, Lupenox is demonstrably different from Lovenox. The two drugs do not even have the same average molecular weight in their mixtures, Well, I am trying to figure out if this is a Dew practical joke - I mean, if they are that different then why hasn't the FDA rejected it outright?